Texas Medical Center (TMC) and the BioInnovation Institute (BII) announced today that three start-ups from BII will join a customized accelerator program tailored for helping startups build their US go-to-market strategy. The specialized accelerator is modeled and builds off the success of the TMC Innovation (TMCi) Health Tech Accelerator program. The Denmark Biobridge between the TMC and the Ministry of Foreign Affairs of Denmark was signed in 2019.
TMC Innovation Factory offers a strategic entry point with training, access, and support for these small and medium-sized enterprises seeking to learn, expand and commercialize in the US market. Founders will be immersed in an intensive program to learn about the potential challenges companies face when entering global business markets and connect with experts who can help them strategically navigate these hurdles.